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Abstract
Backgroundr Inherited thrombocytopenias ｪITsｫ are a heterogeneous group of disor-
ders characterized by 旭ow p旭ate旭et counts and often disproportionate b旭eeding with 
over ザグ genes current旭y imp旭icateds Previous旭y the UK､ GAPP study using who旭e 
exome sequencing ｪWESｫ identified a pathogenic variant in ゲゾ of ジゼ ｪジグ鯵ｫ patients of 
which ゼゲ鯵 had variants in genes known to cause ITs
Aimsr To emp旭oy a targeted next､generation sequencing p旭atform to improve effi-
ciency of diagnostic testing and reduce overa旭旭 costss
科架 科 | 科葦ジゲJOHNSON ET AL.
ゲ科 |科INTRODUCTION
Inherited thrombocytopenias ｪITsｫ are a heterogeneous group of dis-
orders characterized by a sustained reduction in p旭ate旭et count often 
manifesting as a b旭eeding diathesiss Since the discovery of disease 
inheritance patterns in disorders such as Bernard Sou旭ier Syndrome 
ｪBSSｫp genetic studies of thrombocytopenia have been a vita旭 too旭 in 
determining megakaryocyte and p旭ate旭et physio旭ogys1 As a resu旭t of 
para旭旭e旭 who旭e exome and who旭e genome sequencing over the past 
ズ､ ゲグ yearsp we are discovering increasing numbers of nove旭 genes 
and variants with a critica旭 ro旭e in p旭ate旭et productionp physio旭ogyp 
and functions25
To datep there are ザグ genes suspected to cause ゴ葦 separate 
forms of inherited thrombocytopenia making genetic diagnosis com-
plex.6 Howeverp unti旭 recent旭yp IT remained underdiagnosed with 
previous studies on旭y providing a genetic diagnosis in just over ズグ鯵 
of individua旭ss79 A genetic diagnosis provides c旭inica旭 benefits for 
the patientss Some patients with a reduced p旭ate旭et count have had 
unnecessary treatments and procedures such as immunosuppres-
sion and sp旭enectomies and therefore estab旭ishing that they have an 
inherited component to their disease etio旭ogy wou旭d prevent thiss In 
the case of suspected ITP this may be treated with steroids or immu-
nosuppressive drugs with many side effectss Thereforep if such pa-
tients are proven to have an inherited thrombocytopeniap then these 
treatments are unnecessarys Some of the gene mutations in patientsp 
egp RUNX1p resu旭t in patients having a predisposition to hemato旭ogi-
ca旭 ma旭ignancies and once a genetic defect is provenp the information 
can be used to monitor the patientsv hemato旭ogica旭 parameters more 
c旭ose旭ys These a旭旭 high旭ight the need for a definitive genetic diagnosis 
and deve旭opment of a targeted gene､ specific sequencing p旭atform 
wi旭旭 provide a quick and cost effective screening for patients with ITs
As new sequencing 旭ibrary､ capture methods are deve旭opedp the 
speed of samp旭e preparation time is vast旭y reduceds Thusp the re-
cent旭y re旭eased capture methodsp I旭旭umina Nextera Rapid Custom 
Methodsr We have deve旭oped an IT､ specific gene pane旭 as a pre､ screen for patients 
prior to WES using the Agi旭ent SureSe旭ectQXT transposon､ based enrichment systems
Resu旭tsr Thirty､ one patients were ana旭yzed using the pane旭､ based sequencingp of 
whichq ゲグ鯵 ｪザ｠ザゲｫ were identified with a c旭assified pathogenic variantp ゲ葦鯵 ｪズ｠ザゲｫ 
were identified with a 旭ike旭y pathogenic variantp ズゲ鯵 ｪゲ葦｠ザゲｫ were identified with vari-
ants of unknown significancep and ゴザ鯵 ｪゼ｠ザゲｫ were identified with either no variant 
or a benign variants
Discussion and Conc旭usionr A旭though requiring further c旭arification of the impact of 
the genetic variationsp the app旭ication of an IT､ specific next generation sequencing 
pane旭 is a viab旭e method of pre､ screening patients for variants in known IT､ causing 
genes prior to WESs With an added benefit of distinguishing IT from idiopathic throm-
bocytopenic purpura ｪITPｫ and the potentia旭 to identify variants in genes known to 
have a predisposition to hemato旭ogica旭 ma旭ignanciesp it cou旭d become a critica旭 step in 
improving patient c旭inica旭 managements
K E Y W O R D S
b旭eedingp gene mutationsp targeted pane旭 sequencingp thrombocytopenia
Essentials
ｨ Inherited thrombocytopenias are a heterogeneous group of disorders with over ザグ causative genes identified to dates
ｨ We have deve旭oped an IT､specific gene pane旭 to screen patients using the rapid Agi旭ent SureSe旭ectQXT transposon､based enrichment 
systems
ｨ Candidate gene variants were observed in previous旭y imp旭icated IT genes in ゼゼ鯵 of individua旭sq ゲグ鯵 of patients had a c旭assified 
pathogenic variantp ゲ葦鯵 had a 旭ike旭y pathogenic variantp ズゲ鯵 had a variant of unknown significance and ゴザ鯵 had no or a benign 
variant.
ｨ Accurate genetic diagnosis cou旭d improve the c旭inica旭 outcome for this group of patients with disproportionate b旭eeding for their re-
duced platelet count.
葦ジゴ科 |科 科架 JOHNSON ET AL.
Capture Enrichment and Agi旭ent SureSe旭ectQXTp both propose an 
improvement in samp旭e preparation without 旭imitations in sequence 
depthp coveragep and accuracys10 When app旭ied to sma旭旭､ sca旭e cus-
tom gene pane旭sp the preparation time can be reduced to one days In 
additionp DNA input is a旭so reduced a旭旭owing for amp旭ification from 
┑ズグ ng of DNAs11
Due to the high percentage of variants within known IT genes as 
identified by who旭e exome sequencing ｪWESｫ in a previous studyp12 
and the increasing advances in custom pane旭 next generation se-
quencingp an IT､ specific next､ generation sequencing ｪNGSｫ pane旭 
was designed and inc旭uded within the UK､ GAPP patient workf旭ows 
Incorporating a sma旭旭 custom pane旭 prior to WES has the potentia旭 to 
fi旭ter out variants with a genetic etio旭ogy of disease within known IT､ 
causing geness Coup旭ed with the Agi旭ent SureSe旭ectQXT transposon､ 
based system of samp旭e preparationp an increase in the efficiency 
of genetic diagnosisp as we旭旭 as a reduction in the overa旭旭 costp can 
potentially be achieved.
Thereforep in this study we aimed to imp旭ement a NGS pane旭 in 
the UK､ GAPP patient workf旭ows The pane旭 was designed to incor-
porate a旭旭 genes known to be previous旭y associated with ITp effec-
tive旭y pre､ screening patients before WESs The targeted pane旭 a旭so 
takes advantage of a rapid samp旭e preparation technique a旭旭owing 
for quick genetic diagnosis fo旭旭owing patient phenotyping and im-
proving overa旭旭 diagnosis of recruited patientss
ゴ科 |科METHODS
ゴsゲ科|科Patients
Patients were recruited from participating UK hemato旭ogy centerss 
A旭旭 patients had a b旭eeding history taken at the point of examina-
tion and inc旭usion into the studys Most patients suffered from mi旭d 
b旭eeding symptoms inc旭uding cutaneous bruisingp b旭eedingp and 
epistaxis in addition to more severe b旭eeding symptoms in some 
casess Detai旭ed patient c旭inica旭 symptoms re旭ated to b旭eeding that 
were avai旭ab旭e are disp旭ayed in Tab旭e ゲs
The UK､ GAPP study was approved by the Nationa旭 Research Ethics 
Service Committee of West Mid旭andsｦEdgbaston ｪグ葦｠MREグゼ｠ザ葦ｫ and 
participants gave written informed consent in accordance with the 
Dec旭aration of He旭sinkis The GAPP study was registered at wwwsisrctns
org as ﾌISRCTN ゼゼゾズゲゲ葦ゼ and is inc旭uded in the Nationa旭 Institute 
of Hea旭th Research Non､ Ma旭ignant Haemato旭ogy study portfo旭iop 
ｪID､ ゾ芦ズ芦ｫs
ゴsゴ科|科P旭ate旭et counts and morpho旭ogy
P旭ate旭et counts and morpho旭ogy were measured from patients in 
who旭e b旭ood using the Sysmex XN､ ゲグググ ｪn ┎ ザゲｫs The PLT､ F chan-
ne旭 was used to determine p旭ate旭et counts in who旭e b旭ood and the 
immature p旭ate旭et fraction ｪIPFｫs Mean p旭ate旭et vo旭ume ｪMPVｫ was 
determined from the impedance PLT､ I channe旭s A旭旭 samp旭es were 
processed in tandem with trave旭 contro旭ss
ゴsザ科|科P旭ate旭et preparation and p旭ate旭et 
function testing
This study focuses on a subset of patients with a reduction in p旭ate-
旭et counts Previous studies by the UK､ GAPP study group have dem-
onstrated the app旭icabi旭ity of using 旭ight transmission aggregometry 
ｪLTAｫp inc旭uding 旭umiaggregometryp for investigation of PRP samp旭es 
having p旭ate旭et counts exceeding ゲ ┌ ゲグ8｠mL13 and an in､ house f旭ow､ 
cytometry assay to assess p旭ate旭et function in patients having p旭ate-
旭et counts in PRP of 旭ess than ゲ ┌ ゲグ8｠mLs12
ゴsジ科|科Thrombocytopenia､ specific pane旭 sequencing
A thrombocytopenia pane旭 was designed for use as an initia旭 NGS 
ｪNGSｫ sequencing｠pre､ screen before who旭e exome sequencing in 
co旭旭aboration with the Regiona旭 Genetics 旭aboratory at Birmingham 
Womenvs Hospita旭s
The pane旭 was designed using the Agi旭ent SureDesign vザsズsジ 
ｪAgi旭ent Techno旭ogiesp UKｫ design softwares The origina旭 design 
inc旭uded the fo旭旭owing ザグ genesq ABCG5p ABCG8p ADAMTS13p 
ANKRD18Ap ANKRD26p CYCSp FLI1p FLNAp FYBp GATA1p GFI1Bp GP1BAp 
GP1BBp GP5p GP9p HOXA11p ITGA2Bp ITGB3p MKL1p MPLp MYH10p 
MYH9p NBEAL2p ORAI1p RBM8Ap RUNX1p SLFN14p STIM1p TUBB1p and 
WASs The ザグ genes encompassed genes previous旭y associated with 
IT as we旭旭 as some of their re旭ated genes and nove旭 genes identified as 
being associated with thrombocytopenia as part of the GAPP studys 
This pane旭 was app旭ied to patients ジ芦 to 葦ゲ ｪinc旭usiveｫ and patients 
ゼゴ and ゼザp which encompass the first ゲ葦 patients that were ana-
旭yzed by pane旭 sequencings Sequencing probes｠baits were designed 
to cover the fo旭旭owing regionsr a旭旭 coding exons ┓ゲグ bp f旭anking se-
quence from the intron､ exon boundary and the ズ昼UTR and ザ昼UTRs 
Sequencing baits were designed with ゴx density so that each desired 
region was covered by at 旭east two over旭apping probess Baits were 
a旭so designed with the strictest masking stringency settings pos-
sib旭es SureDesign masks repetitive sequences dependent on three 
masking too旭sr RepeatMaskerp WindowMaskerp and Uniqueness ザズ 
tracks The design software uses combinations of a旭旭 three too旭s to 
create three masking stringencies which vary in their inc旭usiveness 
of repeat regionss If baits cou旭d not be found in the highest strin-
gency possib旭ep stringency was decreased unti旭 they cou旭d be founds 
Eighteen genes were covered entire旭y using the highest stringency 
settingp eight genes were covered by a combination of high and 
moderate stringency settingsp and the remaining four genes were 
covered by baits using a combination of a旭旭 three stringency settingss 
Ba旭anced boosting of GC､ rich probes was used which rep旭icated the 
amount of probes within a GC､ rich region by a defined factor to im-
prove capture of these difficu旭t genomic fragmentss The fina旭 design 
incorporated ザザグゾ probes with an overa旭旭 size of ゴゲゴsゲ芦ゾ kbps
For subsequent sequencing beyond the first group of ゲ葦 patients 
as detai旭ed abovep an improved design was uti旭ized to inc旭ude new 
genes imp旭icated in ITs The second version of the design inc旭uded 
a旭旭 probes from the first design with the addition of baits designed 
to sequence the fo旭旭owing genesq ACTN1p ETV6p PF4p and PRKACG. 
科架 科 | 科葦ジザJOHNSON ET AL.










48 5 M 125 9.1 NT P､ Se旭ectin NT NT Cutaneous bruisingp petechiae
49 41 M 30 NA 9.4 NT ADP Normal Cutaneous bruising
50 41 M 30 NA 59.4+ CDジゴb NT NT Cutaneous b旭eeding
51 UNK UNK 162 9.2 NT P､ Se旭ectinp 
GPVI
NT NT Cutaneous b旭eedingp ora旭 cavity 
b旭eeding
52 43 F 131 8.7 14.7+ Normal AA Reduced Cutaneous b旭eedingp epistaxisp 
menorrhagiap Gi b旭eedingp ora旭 
cavity b旭eeding
53 27 F 104 9.1 NT Fibrinogen NT NT Cutaneous b旭eeding
54 12 M 101 10 39.8+ P､ Se旭ectin NT NT Cutaneous b旭eeding
55 UNK F 30 8.6 2.3 P､ Se旭ectin NT NT Cutaneous bruisingp ora旭 cavity 
b旭eedingp menorrhagia
56 15 F 48 10.2 45.2+ Normal NT NT Cutaneous b旭eedingp epistaxis
57 11 F 153 12.1 9.2 NT ADPp AA Reduced Cutaneous bruising｠b旭eeding
58 9 F 82 8.6 6.4 P､ Se旭ectinp 
Fibrinogen
NT NT Cutaneous bruising｠b旭eeding
59 4 M 94 12.3 7.1 Normal NT NT Cutaneous bruising｠b旭eeding
60 UNK F 146 13.4+ 15.8+ CDジゲ Adr Normal Cutaneous bruisingp ora旭 cavity 
b旭eedingp menorrhagia
61 UNK F 76 9.7 3.4 P､ Se旭ectinp 
Fibrinogen
NT NT No observab旭e phenotype
62 34 F 138 13.8+ 17.5+ Normal NT NT Cutaneous b旭eeding
63 13 F 37 14.6+ 16+ P､ Se旭ectin NT NT Cutaneous bruisingp petechiaep 
epistaxis
64 UNK F 105 14.5+ 23.1+ NT Normal Normal Cutaneous bruisingp epistaxis
65 35 F 52 14.9+ 19.4+ P､ Se旭ectinp 
Fibrinogen
NT NT Cutaneous bruising｠b旭eeding
66 18 F 87 10 1.8 P､ Se旭ectinp 
Fibrinogen
NT NT Cutaneous bruising｠b旭eeding
67 22 M 40 13.1+ 15.7+ NT Normal Normal Cutaneous bruising｠b旭eedingp 
epistaxis
68 17 M 191 NT NT NT NT NT Cutaneous b旭eedingp nose 
b旭eeds
69 26 M 69 NT NT NT NT NT Nose b旭eeds
70 34 F 96 NT NT NT NT NT Nonep incidenta旭旭y identified 
thrombocytopenia
71 50 M 128 NT NT NT NT NT Nonep investigated as son has 
thrombocytopenia
72 33 F 14 NT NT NT NT NT Cutaneous b旭eedingp menorrha-
giap acute 旭ymphob旭astic 
旭eukemiap father died of acute 
mye旭oid 旭eukemia
73 29 F 53 11.7 9.1 NT NT NT Cutaneous bruisingp hematuriap 
ora旭 cavity b旭eeding
74 72 M 50 8.4 NT P､ Se旭ectin NT NT Cutaneous bruisingp epistaxis
75 48 F 92 NT NT NT NT NT Cutaneous bruisingp hematomas
76 UNK F 92 10.2 NT Fibrinogen NT NT No observab旭e phenotype
ｪContinuedｫ
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A旭旭 genesp with the exception of PRKACGp were covered by probes 
with the most stringent masking settingss Probes designed for am-
p旭ification and sequencing of PRKACG inc旭uded four probes with the 
旭east､ stringent masking settings app旭ieds Overa旭旭 the new design in-
corporated ザジジゼ probes covering ゴゴゲsザグズ kbps Target enrichment 
was performed for a旭旭 designs using the Agi旭ent SureSe旭ectQXT NGS 
target enrichment kit for I旭旭umina mu旭tip旭exed sequencing ｪAgi旭ent 
Techno旭ogiesｫs Samp旭e preparation fo旭旭owed the workf旭ow out旭ined 
in the manufacturervs instructions ｪFigure ゲｫs Due to the re旭ative 
sma旭旭 size of the capture 旭ibrary a旭旭 size､ re旭ated steps fo旭旭owed the 
methodo旭ogy for capture 旭ibraries ┑ザ Mbs In the preparation for hy-
bridization ゼズグ ng of gDNAp di旭uted in a vo旭ume of ゲゴ μL was useds
A maximum of ゲ葦 samp旭es were prepared per runs DNA samp旭es 
were quantified using BR and High Sensitivity ｪHSｫ Qubit dsDNA 
f旭uorometric quantification kits and were ana旭yzed using a Qubit 
ゴsグ F旭uorimeter ｪThermoFisherp UKp ﾌQザゴ芦ズジ for HS kitｫ in initia旭 
samp旭e preparations Purification steps uti旭ized Agencourt AMPure 
XP magnetic capture beads ｪBeckmanCou旭terp UKp ﾌA葦ザ芦芦グｫs DNA 
quantity and qua旭ity was assessed at two separate points through-
out the protoco旭 using an Agi旭ent ゴゴググ Tapestation system and 
associated Dゲグググ and high sensitivity Dゲグググ screen tape ｪﾌズグ葦ゼ､ 
ズズ芦ゴ for Dゲグググp ﾌズグ葦ゼ､ ズズ芦ジ for HS Dゲグググｫp and reagents ｪinc旭ud-
ing 旭adder and samp旭e buffersｫ ｪﾌズグ葦ゼ､ ズズ芦ザ for Dゲグググ reagentsp 
ﾌズグ葦ゼ､ ズズ芦ズ for HS Dゲグググ reagentsｫ ｪAgi旭ent Techno旭ogiesｫs 
Dynabeads MyOne Streptavidin Tゲ magnetic beads were used for 
hybrid capture ｪThermoFisherp ﾌ葦ズ葦グゲｫs Index tags were added 
using the SureSe旭ectQXT Pゼ and Pズ dua旭 indexing primerss A旭旭 ther-
mocyc旭ing steps were performed using a Bio､ Rad DNA Engine 
Tetrad ゴ Therma旭 Cyc旭er ｪBio､ Radp UKｫs Magnetic separation was 
achieved using a DynaMag､ ゾ葦 Side magnet ｪThermoFisherｫs
Samp旭es were then poo旭ed for mu旭tip旭exed sequencing so that 
each index､ tagged samp旭e was in equimo旭ar amounts in the poo旭s 
For each samp旭e the fo旭旭owing formu旭a was used to determine the 
amount of index samp旭e to uses
where V ｪfｫ ┎ Fina旭 desired vo旭ume of poo旭q C ｪfｫ ┎ Desired fina旭 con-
centration of a旭旭 DNA in poo旭q ﾌ ┎ is the number of the indexesq C 
ｪiｫ ┎ Initia旭 concentration of each samp旭es
A fina旭 desired vo旭ume of poo旭 of ゴグ μL was used and a fina旭 con-
centration of ジ nmo旭｠Ls In a旭旭 cases ゲ葦 indexes were poo旭eds
To achieve an optima旭 c旭uster densityp a fina旭 concentration 
of ゲグ､ pmo旭｠L DNA was useds DNA was first旭y denatured by 
the addition of ズ μL of グsゴ mo旭｠L NaOH to ズ μL of ジ nmo旭｠L 
pooled library and allowed to incubate at room temperature 
ｪｶゴグﾀCｫ for ズ minutes before adding ゾゾグ μL of pre､ chi旭旭ed HTゲ 
hybridization buffer was added to achieve a ゴグ､ pmo旭｠L so旭u-
tion. A 300- μL a旭iquot of the ゴグ､ pmo旭｠L so旭ution was di旭uted 
with 300 μL HTゲ to achieve a fina旭 concentration of ゲグ pmo旭｠L 
in 600 μLs
Fina旭旭y sequencing was performed using an I旭旭umina MiSeq 
ｪI旭旭uminap UKｫ and MiSeq vゴ ザググ Cyc旭e Reagent Kits ｪI旭旭uminap 
ﾌゲズグザザ葦ゴ葦ｫs Samp旭e sheets were designed to a旭旭ow for the use of 
custom primers and no adaptor trimmings Sequencing fo旭旭owed a 
Nextera XT samp旭e preparation kit and amp旭icon chemistrys
Sequence a旭ignmentp annotationp categorisation and variant 
ca旭旭ing was performed using the SureCa旭旭 vザsズ software ｪAgi旭ent 
Techno旭ogiesｫ and the GenA旭igners ザsグ a旭ignment too旭 ｪAgi旭ent 
Techno旭ogiesｫs Post a旭ignedp annotatedp and categorized sequence 
data was ana旭yzed using a persona旭ized bioinformatics pipe旭ine as dis-
cussed be旭ows
ゴsズ科|科Bioinformatics pipe旭ine to determine 
candidate variants
Sequence data generated using the IT､ specific NGS pane旭 was ana-
旭yzed using an adaptation of the pipe旭ine deve旭oped for the ana旭ysis 
of WES datas12 Variants were initia旭旭y fi旭tered on frequencyp exc旭ud-
ing variants with a MAF └グsグゲ in the ゲグググ､ G databases Synonymous 
variants not predicted to change the amino acid sequence in the 
protein coding transcripts were then exc旭udeds As the pane旭 was 













77 15 F 76 9.4 13.5+ Normal NT NT Ora旭 cavity b旭eedingp 
menorrhagia
78 UNK M 101 13.9+ 14.4+ Normal Adr Normal Cutaneous b旭eeding
Average p旭ate旭et count ┎ 芦芦 ┌ ゲグ9｠L ｪnorma旭 range to ゴ SD ゲジゼ､ ザゴゼ ┌ ゲグ9｠Lp n ┎ ジグｫs Average MPV ┎ ゲゲsゲ fL ｪmean norma旭 range to ゴ SD ゼs芦､ ゲゴs葦ゾ fLp 
n ┎ ジグｫs IPF was avai旭ab旭e for ゴグ patients and varied between ゲs芦､ ズゾsジ鯵 ｪnorma旭 range ゲsザ､ ゲグs芦鯵p n ┎ ジグｫs Patients with an observed macro and micro 
thrombocytopenia are denoted by a ┊ and ､ p respective旭yp fo旭旭owing their most recent ana旭yzed MPVs Secondary qua旭itative defects are abbreviated to 
the fo旭旭owingq ｪCDジゲｫ reduction in the resting ce旭旭 surface 旭eve旭s of CDジゲp ｪCDジゴbｫ reduction in resting ce旭旭 surface 旭eve旭s of CDジゴbp ｪADPｫ reduction in 
response upon ADP stimu旭ation indicating a possib旭e defect in the Gi pathwayp ｪAAｫ reduction ｪcyc旭ooxygenase pathway defectｫp ｪAdrｫ reduction 
ｪThromboxane receptor pathway defectｫp ｪGPVIｫ reduction in surface GPVI quantityp ｪP､ se旭ectinｫ reduction ｪp旭ate旭et a旭pha､ granu旭e｠secretion defectｫp 
ｪfibrinogenｫ reduction in the binding of fibrinogen to activated p旭ate旭etsp ｪATP secretionｫ reduction in ATP secretion upon stimu旭ation with PAR､ ゲ pep-
tide 100 μmo旭｠Ls B旭eeding diathesis of each individua旭 is summarized under b旭eeding phenotypes
AAp arachadonic acidq ADPp Adenosine diphosphateq Adrp adrena旭ineq ATPp Adenosine triphosphateq GPVIp G旭ycoprotein VIq IPFp immature p旭ate旭et frac-
tionq LTAp 旭ight transmission aggregometryq MPVp mean p旭ate旭et vo旭umes ┊ denotes an e旭evated MPV｠IPFq NA indicates parameter was tested but resu旭ts 
were inconc旭usiveq NT indicates parameter was not tested due to degraded or 旭imited samp旭eq UNK indicates the parameter was not knowns
TABLE  ゲ科 ｪContinuedｫ
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fi旭tered dependent on their genomic 旭ocation within the coding re-
gion ┓ゲグ bp of intron､ exon boundariess The UTRs were inc旭uded 
in bait design to a旭旭ow detection of variants within the ズ昼 UTR of 
ANKRD26 so that a旭旭 variants occurring within the ズ昼UTR of genes 
were ana旭yzed individua旭旭ys Candidate variants identified were scru-
tinized using the same in si旭ico pathogenicity prediction software 
and variant c旭assification system as candidates from WES ana旭ysis 
as out旭ined previous旭ys12 Fina旭旭yp pathogenicity of variants was de-
termined and ca旭旭ed using the consensus guide旭ines as set out by 
the American Co旭旭ege of Medica旭 Genetics and Genomics and the 
Association for Mo旭ecu旭ar Patho旭ogy ｪhence forth referred to as the 
ACMG guide旭inesｫs14
ゴs葦科|科Qua旭ity of sequence datap average number of 
variants, and sequence coverage
A旭旭 individua旭 DNA samp旭es were processed and passed QC at 
two points during samp旭e preparations Prior to samp旭e poo旭ing 
an average ca旭ibrated DNA concentration of ゴsゾズゼ ng｠μL and a 
mo旭arity of ゲザsザ nmo旭｠L was observed across a旭旭 samp旭ess A旭旭 se-
quencing runs passed interna旭 QC that is used within the West 
Mid旭ands Regiona旭 Genetics Service at the Birmingham Womenvs 
Hospita旭 and interna旭 QC from the SureCa旭旭 ana旭ysis softwares 
A旭旭 candidate variants identified were c旭assified as high qua旭ity 
mapped variants with a qua旭ity score of ゴズズ using the SureCa旭旭 
softwares
ザ科 |科RESULTS
ザsゲ科|科Phenotyping of IT patient cohort recruited to 
the study
A旭旭 ザゲ unre旭ated cases inc旭uded in this study underwent c旭inica旭 
eva旭uation to exc旭ude idiopathic thrombocytopenic purpura ｪITPｫ 
ｪfo旭旭owing a re旭ative旭y stab旭e reduced p旭ate旭et count over timeｫ and 
other nonp旭ate旭et disorders inc旭uding von Wi旭旭ebrand disease and 
inherited coagu旭ation factor deficienciess Subsequent ana旭ysis after 
enro旭ment iso旭ated this group of patients with a suspected p旭ate旭et 
count 旭ess than ゲズグ ┌ ゲグ9｠L and therefore suspected to have an in-
herited thrombocytopenia of unknown etio旭ogy ｪTab旭e ゲｫs P旭ate旭et 
counts varied between ザグ and ゲ葦ゴ ┌ ゲグ9｠L among the ザゲ indi-
vidua旭s with a mean count of 芦芦 ┌ ゲグ9｠L ｪTab旭e ゲｫ ｪnorma旭 range to 
two standard deviations ゲジゼ､ ザゴゼ ┌ ゲグ9｠Lp n ┎ ジグｫs Patients with a 
p旭ate旭et count between ゲズグ､ ゴググ ┌ ゲグ9｠L were retained for ana旭y-
sis within the study under the stipu旭ation that there was a shared 
phenotype within the patient and re旭ated affected fami旭y mem-
bers and that a prior p旭ate旭et count has been be旭ow ゲズグ ┌ ゲグ9｠Ls 
Mean p旭ate旭et vo旭umes were between 芦s葦､ ゲジs葦 fL ｪn ┎ ゴザｫ ｪmean for 
hea旭thy contro旭s ┓ゴ SD ┎ ゼs芦､ ゲゴsジ fLｫsThe immature p旭ate旭et fraction 
ｪIPFｫ mean in the patients was ゲゼ鯵 of the tota旭 p旭ate旭et count ｪrange 
ゲs芦､ ズゾsジ鯵ｫp n ┎ ゴグ ｪnorma旭 range ゲsザ､ ゲグs芦鯵p n ┎ ジグp mean ジsジ鯵ｫpthe 
higher va旭ues ref旭ecting abnorma旭 bone marrow p旭ate旭et production 
or thrombopoiesiss
F I G U R E  ゲ科Samp旭e preparation 
workf旭ow for the IT､ specific next､ 








Prepared DNA library amplicons
Genomic locations of interest
Design target sequences in
SureDesign
SureSelect Capture Library
Hybridize using SureSelect Capture Library
Capture Library/prepared DNA library hybrids
Capture hybrids on streptavidin-coated
magnetic beads
Captured,target-enriched DNA library
PCR amplify using Dual
Indexing primers
Dual-indexed, target-enriched DNA library
Pool libraries for multiplex sequencing
SureSelect-enriched dual-indexed NGS samples
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LTA was used to assess p旭ate旭et function for seven patients and 
f旭ow cytometry a旭one was performed for samp旭es from ゲゼ patientss 
P旭ate旭ets from individua旭s with a border旭ine p旭ate旭et count in PRP 
of between グsゲ and グsゲズ ┌ ゲグ9｠L were assessed using both assays 
ｪn ┎ ザｫs P旭ate旭et function studies revea旭ed the suggestion of the pres-
ence of a secondary qua旭itative defect in addition to the reduction in 
p旭ate旭et count in ゲゾ of ゴジ ｪゼゾ鯵ｫ ｪTab旭e ゲｫ of the overa旭旭 cohort of pa-
tients testeds
ザsゴ科|科IT､ specific NGS pane旭
On averagep ザゴ葦 variants were noted in samp旭es from each individua旭 
ana旭yzed by the IT､ specific NGS pane旭s This ranged from ゴ葦ズ to ジググ 
variants across a旭旭 samp旭es ana旭yzeds Fo旭旭owing exc旭usion of synon-
ymous variantsp an average of ゼザ variantsp having a MAF └グsグゲ in 
the ゲグググ､ G database were noted per individua旭s When the ExAC 
database was interrogated for each of the variants identified in non 
UTR regions on旭y those variants disp旭ayed in Tab旭e ザ were of a rare 
frequency ｪMAF ┑グsグゲｫs
Average coverage across the targeted regions was in excess of 
ゾズ鯵 for a旭旭 samp旭es ana旭yzeds An average read depth of ザ芦グ was 
noted at the site of each variations This read depth was not observed 
be旭ow ゲゴゲ at each point of a旭旭 candidate variants and reached a fi旭-
tered read depth of 芦ゴザs
ザsザ科|科Va旭idation of IT､ specific NGS pane旭
Va旭idation of the IT､ specific NGS pane旭 was performed by ana-
旭yzing the pane旭vs sensitivity in detecting eight variants iden-
tified previous旭y by WES ana旭ysis and confirmed by Sanger 
sequencings Variantsp at the time of va旭idationp were 旭ike旭y 
candidate variants and inc旭ude variants in genes not known 
previous旭y to cause IT ｪsee Tab旭e ゴｫs A旭旭 variantsp exc旭uding a 
previous旭y identified frameshift causing insertion in TUBB1; 
csゲグ芦グｧゲグ芦ゲinsGp psLeuザ葦ゲA旭afsｰゲゾ previous旭y identified using 
WES in patient ザゲp12 were successfu旭旭y identifiedp presum-
ab旭y due to the sequence context around this genomic regions 
A旭旭 known candidate variants tested were the on旭y candidate 
variants fo旭旭owing bioinformatics ana旭ysis of pane旭 sequencing 
resu旭ts in each patients
ザsジ科|科Candidate variants observed and variant 
prevalence in 31 new patients
In tota旭p DNA samp旭es from ザゲ new patients were ana旭yzed by an 
IT､ specific NGS pane旭s A旭旭 patientsp with the exception of 葦ジp were 
sing旭e affected casess Patient 葦ジ forms part of a pedigree of four 
affected fami旭y members which wi旭旭 be discussed in more detai旭 in 
the discussion sections Fo旭旭owing post､ sequencing bioinformatics 
ana旭ysis candidate variants previous旭y imp旭icated in IT genes were 
observed in ゼゼ鯵 of individua旭s ｪTab旭e ザｫs In tota旭p ザゼ variants were 
noted in the ゴジ patients observed with a genetic variant in a gene 
previous旭y known to cause ITs Seven patients were observed with 
two variants in two different genes and three patients were noted 
to have three variantss No patients were noted with two variants 
occurring within the same gene and a旭旭 variants were observed in 
a heterozygous states One variantq GP5q cs芦葦ゼG┒Cp psMetゴ芦ゾI旭ep 
was noted in two unre旭ated patientsp ズゼ and ズ芦s
The majority of variants identified were missense variants affecting 
a sing旭e amino acids This equated to 芦ゾ鯵 of the variants observeds In ad-
ditionq one ズ昼UTR start gain was noted in patient ジ芦 ｪTUBB1q cs､ 芦芦G┒Cｫp 
one frameshift causing de旭etion was noted in patient ズグ ｪGP1BB; 
csde旭ゲゴグ､ ゲジゴp psArgジゴCys fsｰゲジｫp one stop 旭oss variant was noted in pa-
tient ズジ ｪGATA1q csゲゴジグT┒Cp psー ジゲジArg┊ジゲｫp and one nonsense causing 
SNV was observed in patient 葦グ ｪITGA2Bq csゴゲゼ葦A┒Tp psLysゼゴ葦ｰｫs
Of the ザゼ variantsp ゲゲ ｪザグ鯵ｫ were nove旭 and not previous旭y iden-
tified in any of the databases scrutinizeds Twenty､ six variants have 
been observed previous旭y and the preva旭ence of these variants in 
the ExAC databasep un旭ess otherwise statedp is disp旭ayed in Tab旭e ザs 
When comparing a旭旭 previous旭y observed variants an average MAF 
of グsググゴズ葦 is noteds A旭旭 variants were observed at a frequency of 
旭ess than グsグゲ and a旭旭 previous旭y identified variantsp with the excep-
tion of rsゲゲゲズゴゼゼザ芦 which was present within the 旭atest bui旭d of 
dbSNPs Four pathogenic or 旭ike旭y pathogenic variants were identi-
fied that are previous旭y known to cause ITs These were found in pa-
tientsq ズジ ｪGATA1q csゲゴジグT┒Cp psー ジゲジArg┊ジゲｫp ズゾ ｪRUNX1q csザ芦葦C┒Ap 
Patient Gene Variation Type
2 ANKRD26 cs､ ゲゴ葦T┒G ズ昼､ UTR
17 RUNX1 csGゴザ葦Ap pTrpゼゾｰ Nonsense
20 RUNX1 csGザザゴAp psG旭yゲグ芦Ser Partia旭 heterozy-
gous missense
21 RUNX1 csジゴゼ ┊ ゲG┒T Sp旭ice site variant
26 SLFN14 csA葦ズゴGp psLysゴゲ芦G旭u Missense




36 WAS csGゲジズ葦Ap psG旭uジ芦葦Lys X､ 旭inked Missense
41 ANKRD18A csゴザゾズｧゴザゾゼde旭p psG旭uゼゾゾde旭 Non､ frameshift 
causing de旭etion
TABLE  ゴ科Eight patients and the eight 
known candidate variants12 representing a 
range of mutation types uti旭ized for the 
va旭idation of the IT､ specific next､ 
generation sequencing pane旭
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psA旭aゲゴゾG旭uｫp ゼグ ｪGFI1Bq csズグザG┒Tp psCysゲ葦芦Pheｫp and 葦ジ ｪMYH9; 
csゴゲズゴC┒Tp psArgゼゲ芦Trpｫsザpゲズ･ゲゼ
Patient ズジp a ゲゴ､ year､ o旭d ma旭e with a history of cutaneous b旭eed-
ing and a mi旭d reduction in p旭ate旭et count ｪゲグゲ ┌ ゲグ9｠Lｫ was noted 
with a stop 旭oss variant in GATA1q csゲゴジグT┒Cp psー ジゲジArg┊ジゲs The 
predicted effect of variation is a 旭oss of the wi旭d type stop codon and 
extension of the protein by ジゲ amino acidss Most reported variants 
within GATA1 occur within the N､ termina旭 zinc finger domainp 旭ead-
ing to a disruption of the binding of GATAゲ to FOGゲs The stop､ 旭oss 
variant noted in patient ズジp was first identified in a 葦ゼ､ year､ o旭d ma旭e 
proband who suffers from easy bruisings16 The patientvs p旭ate旭et 
counts varied between 芦葦 to ゾジ ┌ ゲグ9｠L at different times of testing 
and no other differences in hemato旭ogica旭 ce旭旭 numbers were noteds 
The patient was initia旭旭y sequenced due to the presence of a rare X､ 
旭inked b旭ood group Luｪa､ b､ ｫ phenotype which resu旭ts in the marked 
decrease in expression of Lutheran g旭ycoprotein on the erythrocyte 
ce旭旭 surfaces To datep sero旭ogica旭 ana旭ysis using f旭ow cytometry to 
ana旭yze the presence of Lutheran on the erythrocyte ce旭旭 surface 
has not been undertaken in patient ズジs A旭so the presence of giant 
occasiona旭 macrothrombocytesp a marker of the pub旭ished pheno-
typep have not been observed in patient ズジ in routine histo旭ogica旭 
examination.
A previous旭y identified causative variant was noted in RUNX1 
in patient ズゾs The missense variantp csザ芦葦C┒Ap psA旭aゲゴゾG旭up was 
found in addition to a missense variant in ITGA2Bs The variant has 
previous旭y been reported to be causative of FPD｠AML in three pa-
tients from a sing旭e pedigrees15 A旭旭 three patients were identified 
with the psA旭aゲゴゾG旭u germ旭ine mutation causative of FPD｠AMLs 
A旭旭 patients deve旭oped AML as a resu旭t of a secondary somatic 
event occurring within RUNX1 progressing to patient death in a旭旭 
casess Patient ズゾ is a ma旭e with a mi旭d reduction in p旭ate旭et count 
to ゾジ ┌ ゲグ9｠Ls Fo旭旭owing p旭ate旭et function testing no reduction in 
p旭ate旭et secretion ｪa ha旭旭mark of variants within RUNX1ｫ was noteds 
Howeverp it is high旭y 旭ike旭y that the variant observed in RUNX1 is 
causative of the hemostatic phenotype observeds Whether the 
variant within ITGA2B is additive to the phenotype is un旭ike旭y as 
the p旭ate旭et count is considered mi旭d in severity but may warrant 
further investigations
Patient 葦ジp is the on旭y patient ana旭yzed by the IT､ specific pane旭 
for whom affected fami旭y members were a旭so recruited to the studys 
The patient forms part of a pedigree of four affected fami旭y members 
with a shared phenotype and c旭inica旭 symptomss Fo旭旭owing ana旭ysis 
of the IT､ specific pane旭 sequencingp a missense variant was identi-
fied in MYH9q csゴゲズゴC┒Tp psArgゼゲ芦Trps This variant has been noted 
once previous旭y in a patient initia旭旭y diagnosed with MYHゾ､ RDs3 The 
variant occurs within the motor domain of MYHゾ and is associated 
with an increased risk of deafness and nephritisp howeverp no sec-
ondary symptoms have previous旭y been reported in patient 葦ジ or 
any of the affected fami旭y members a旭so recruited to the UK､ GAPP 
studys However patients such as this shou旭d be monitored regu旭ar旭y 
for signs of kidney diseases Two variants previous旭y identified by 
WES ana旭ysis of 葦ゾ patients were a旭so identified in patients ana旭yzed 
by the IT､ specific pane旭 sequencings These variantsq CYCSq csゲズズC┒Tp 
psA旭aズゴVa旭p and ITGA2Bq csゴゲゼ葦A┒Tp psLysゼゴ葦ｰ were identified in pa-
tients ズグ and 葦グp respective旭ys
ザsズ科|科Conservationp pathogenicity predictionp and 
variant classification
Conservation at the site of variation was determined by Phy旭oP 
and PhastCons in si旭ico softwares Conservation scores for a旭旭 vari-
ants occurring within known IT､ causing genes in the ザゲ patients 
are shown in Tab旭e ザs Average scores of ザsザゴ芦芦ゼ and グs芦ゴゾズゼゲ 
were observed across a旭旭 variants in Phy旭oP and PhastCon ana旭y-
sisp respective旭ys The majority of variants occurred at sites of high 
conservation and the two methodo旭ogies used were in agreement 
in a旭旭 instancess
Pathogenicity was predicted using in si旭ico prediction software 
as disp旭ayed in Tab旭e ザs C旭assification often varied amongst the soft-
ware used for each variant indicating the benign potentia旭 of the 
variants observeds
In tota旭p of the ザゼ tota旭 variants noted across a旭旭 patients investi-
gatedp three variants were c旭assified as wpathogenicx and five w旭ike旭y 
pathogenicx when considering the ACMG consensus guide旭iness The 
remaining ゴゾ variants without a positive prediction of pathogenic-
ity were c旭assified as of wunknown significancesx On旭y two variants 
disp旭ayed supporting evidence for a benign c旭assifications Of the ゴジ 
patients where a genetic variant was identified this c旭assification 
predicted equated to ゲゴ鯵 ｪザ of ゴジｫ of patients with a pathogenic 
variantp ゴゲ鯵 ｪズ of ゴジｫ with a 旭ike旭y pathogenic variantp and 葦ゼ鯵 ｪゲ葦 of 
ゴジｫ variants of unknown significances
ジ科 |科DISCUSSION
An IT gene･specific NGS pane旭 was deve旭oped in order to pre､ screen 
patients prior to WESs The aim was to fi旭ter out patients with vari-
ants in known IT､ causing genes a旭旭owing subsequent focus on WES 
for patients who may harbor variants in nove旭 geness In additionp the 
cost imp旭ications were an important consideration given that the 
WES was more than four times as expensive compared with targeted 
pane旭 sequencings
A旭旭 sequencing passed QC at a旭旭 points throughout samp旭e 
preparation and QCp c旭uster density and overa旭旭 sequencing data 
was sufficient when compared with routine sequencing using a旭-
ternate capture methods performeds A旭though considered a rapid 
capture methodp Agi旭ent SureSe旭ectQXT samp旭e preparation does 
not quite reach optimum depth of coveragep evenness and target 
enrichment when compared with a旭ternate methods of capture 
inc旭uding Agi旭ent SureSe旭ectXT.ゲグpゲ芦 When app旭ied to our custom 
designed pane旭p average coverage easi旭y exceeded a universa旭旭y 
accepted minimum ゴグx coverage for efficient旭y ca旭旭ing variants 
and an average read depth of ザ芦グ was identified at the points of 
variation.19
With a GC content of ゼザ鯵p GP1BB often suffers from a reduction 
in coveragep which is why in WES ana旭ysis the gene was manua旭旭y 
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TABLE  ザ科Variants identified by ana旭ysis of the IT､ specific next､ generation sequencing pane
Patient Geneｪsｫ Genomic variation Protein effect Variation type Prevalence PhyloP
48 ABCG5 csゴゾザC┒G psA旭aゾ芦G旭y Missense グsググズ ｪrsゲジズゲズジゾザゼｫ 5.277
ABCG8 csゲ葦葦ゼT┒C psPheズズ葦Ser Missense グsグググゾ ｪrsズジ芦グゾ芦ゼジゴｫ 2.914
TUBB1 cs､ 芦芦G┒C ズ昼UTR start gain グsググジ ｪゲグググGｫ ｪrsゲズググゼゴジザジｫ
49 ABCG5 csゲ芦葦ジA┒G psMet葦ゴゴVa旭 Missense グsググズジゲ ｪrsゲジグザゼジゴグ葦ｫ ┋グsゼジ芦
NBEAL2 cs葦葦ザゲG┒A psAspゴゴゲゲAsn Missense Novel 5.515
50 CYCS csゲズズC┒T p.Ala52Val Missense Novel 5.962
GP1BB c.del120- 142 psArgジゴCys fsｰゲジ Frameshift de旭etion Novel
51 FLI1 cs芦ゲゴG┒A psArgゴゼゲG旭n Missense Novel 5.983
MYH9 csゴ芦ゼゴG┒A psA旭aゾズ芦Thr Missense グsグググゾ ｪrsゲズゲグザ葦ズゼグｫ 6.088
52 FLNA csズゾジ芦C┒T psSerゲゾ芦ザLeu Missense グsググゴ葦 ｪrsゲ芦ゼグゴゾザグゾｫ 5.952
53 FLNA csゼズ芦ザA┒T psAspゴズゴ芦Va旭 Missense Novel 4.858
MYH9 csゼC┒G psG旭nザG旭u Missense グsググゲズ ｪrsズ葦ゴググ芦ゾジｫ 4.643
TUBB1 csゲゲゾゾG┒A psSerジググAsn Missense Novel 5.88
54 GATA1 csゲゴジグT┒C psー ジゲジArg┊ジゲ Stop 旭oss Known 2.408
55 GP1BA csゴグ葦C┒T psPro葦ゾLeu Missense グsググゲ芦ゼゴ ｪrsゲザ芦芦ゴズ葦ジグｫ ┋ゲsジグゼ
56 GP1BB csゴジゴT┒G psLeu芦ゲArg Missense Novel ┋グsゲ葦ゴ
57 GP5 cs芦葦ゼG┒C psMetゴ芦ゾI旭e Missense グsググザゲグゲ ｪrsゲジゴジジググゴ芦ｫ 2.516
58 GP5 cs芦葦ゼG┒C psMetゴ芦ゾI旭e Missense グsググザゲグゲ ｪrsゲジゴジジググゴ芦ｫ 2.516
STIM1 csゲ芦ゴA┒G psG旭u葦ゲG旭y Missense グsググググジゾジゲ ｪrsゴグゴゲ葦グゼズズｫ 2.851
59 ITGA2B cs芦芦葦G┒A psG旭yゴゾ葦Arg Missense Novel 3.205
RUNX1 csザ芦葦C┒A psA旭aゲゴゾG旭u Missense Known ｪrsゴ葦ゼ葦グゼグゴ葦ｫ 6.077
60 ITGA2B csゴゲゼ葦A┒T psLysゼゴ葦ｰ Nonsense Novel 1.419
61 ITGA2B csゴジゲゼG┒A psSer芦グ葦Asn Missense Novel 0.148
WAS csゾゾズT┒C p.Val332Ala Missense グsググズゲ ｪrsゴゼザゼゼゾゾｫ 0.096
62 MKL1 csズ葦ゾC┒T psProゲゾグLeu Missense グsグググゲ葦 ｪrsゴググザグゾゾズズｫ 3.693
63 MKL1 csゲジゾゴG┒C psVa旭ジゾ芦Leu Missense グsグググググ芦葦ザ芦 ｪrsゲゾゾゼズグゴゴズｫ 2.138
64 MYH9 csゴゲズゴC┒T psArgゼゲ芦Trp Missense Known 2.044
65 MYH9 csズグゼジG┒A psA旭aゲ葦ゾゴThr Missense Novel 4.087
66 MYH10 csゴゾ芦ゼC┒T p.Ala965Val Missense 0.0079 4.822
NBEAL2 csジザ葦ゲC┒T psThrゲジズジMet Missense 0.0001 3.227
67 TUBB1 csジゴゲG┒A psG旭yゲジゲArg Missense グsググググザゴゾズ ｪrsゼゼ芦ゾゼズ芦ゴゼｫ 5.803
68 ABCG8 csゲ葦ゴゾG┒T psArgズジザSer Missense グsグググゴ ｪrsゴグゲ葦ゾグ葦ズジｫ 5.057
69 ACTN1 csゲザ葦C┒T psArgジ葦Trp Missense 0.00000827 5.532
70 GFI1B csズグザG┒T psCysゲ葦芦Phe Missense グsグググ葦グゲゲ ｪrsズゴゼゴゾゼ芦ゾ葦ｫ 4.334
71 RUNX1 cs芦葦T┒C psLeuゴゾSer Missense グsグゲ葦ゴゾ ｪrsゲゲゲズゴゼゼザ芦ｫ 0.683
NBEAL2 csジグ芦ズG┒A psArgゲザ葦ゴG旭n Missense 0.00000829 1.666
GFI1B csズズゲG┒C psArgゲ芦ジPro Missense 0.00000746 1.433
7278 Unknown
ｪContinuedｫ
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Patient Phastcons Mutation taster PolyPhen- 2 SIFT Provean ACMG criteria C旭assification
48 1 D D D D PPザ Uncertain significance
1 D D D D PPザ Uncertain significance
Uncertain significance
49 0 P B T N BPジ Uncertain significance
0.997 D D D D PMゴp PPザ Uncertain significance
50 1 D B D D PMゴ Uncertain significance
D PMゴp PPザp PMジp PPジ Like旭y pathogenic
51 1 D D D D PMゴp PPザ Uncertain significance
1 D B T N Uncertain significance
52 1 P D D D Uncertain significance
53 1 D D D D PMゴp PPザp Uncertain significance
0.998 D B D N Uncertain significance
0.972 D B D N PMゴ Uncertain significance
54 0.572 P PMジp PSゲp PPズ Like旭y pathogenic
55 0 P B D D Uncertain significance
56 0.175 P D D D PMゴp PPジ Uncertain significance
57 0.55 P B D D Uncertain significance
58 0.55 P B D D Uncertain significance
1 D B D D Uncertain significance
59 0.999 D B D D PMゴ Uncertain significance
1 D D D D PPザp PSゲp PSザ Pathogenic
60 0.957 D PMゴp PMジp PVSゲp PPジ Pathogenic
61 0.286 P B T N PMゴ Uncertain significance
0 P B T N BPジ Uncertain significance
62 0.987 D B T D Uncertain significance
63 0.998 D B T N Uncertain significance
64 1 D D D D PPザp PSゲp PSザp PM 
ｪsegregationｫp PPジ
Pathogenic
65 1 D B T N PMゴ Uncertain significance
66 1 D B D D Uncertain significance
0.999 D B T N Uncertain significance
67 1 D D D D PPザ Uncertain significance
68 1 D D D N PMゴ Uncertain significance
69 1 D D D D PSゲp PMゴp PPザ Like旭y pathogenic
70 1 D D D D PSゲp PMゴp PPザ Like旭y pathogenic
71 1 P D T N Uncertain significance
1 P D T N Uncertain significance
0.995 D D D D PSゲp PMゴp PPザ Like旭y pathogenic
7278 N/A
Preva旭ence is shown in the ExAC consortium if not specified otherwises Phy旭oP and Phastcons scores are showns Variants are noted as Dp disease 
causing and Pp po旭ymorphism in MutationTasterq Dp damaging and Tp to旭erated in SIFTq Dp de旭eterious and Np neutra旭 in Proveanq Dp damaging and 
Bp benign in Po旭yPhen､ ゴ in si旭ico pathogenicity prediction softwares Phy旭oP scores vary between ┋ゲジ and ┊葦 and measure conservation at each 
individua旭 basep sites predicted to be conserved are assigned a positive scorep fast､ evo旭ving sites are assigned a negative scores Mutationtaster 
uses a Beyes c旭assifier to predict the effect of a mutation from a feed a c旭assifierss SIFT damaging prediction score ┎ ┑グsグズs Provean de旭eterious 
score ┎ ┑ ┋ゴsズs Po旭yPhen､ ゴ predictions are appraised qua旭itative旭y as benign or damagings The ACMG consensus guide旭inesp inc旭uding supporting 
evidencep are a旭so showns
TABLE  ザ科 ｪContinuedｫ
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ana旭yzeds Uti旭izing the NGS pane旭 there was no drop in coverage 
within GP1BB for a旭旭 patients ana旭yzed and two variantsp in patients 
ズグ and ズ葦p were identifiedp which may be causative of diseases This 
represents variants which cou旭d be potentia旭旭y missed by other se-
quencing methodo旭ogies and potentia旭 advantage of pane旭､ based 
sequencings
In tota旭p candidate variantsp that cou旭d be considered for fur-
ther ana旭ysisp were identified in ゼゼ鯵 of individua旭s when ana旭yzed 
by the IT､ specific pane旭s This detection rate is in keeping with 
other recent previous 旭arge､ sca旭e targeted pane旭 sequencing stud-
ies and the app旭ication of WES to patients with IT of unknown eti-
o旭ogysジpゲゴpゴグpゴゲ One possib旭e exp旭anation for the inf旭ated detection 
rate for pane旭 based p旭atforms is the re旭ative increase in average 
read coverage when compared to WES ana旭ysisp especia旭旭y at the 
point of variations
When comparing preva旭encep howeverp next､ generation pane旭 se-
quencing identifies a 旭arge number of variants that have been previ-
ous旭y identified with a 旭ow MAFs This may be an indication that the 
variants are to旭erated within the popu旭ation and are not causative 
of diseases One way to determine this wou旭d be to ana旭yze the co､ 
segregation of variants within affected｠unaffected re旭atives of the 
index casess This has the potentia旭 to ru旭e out or further strengthen 
any identified variants but unfortunate旭y in this study this information 
was unavai旭ab旭es The most comprehensive database of genetic vari-
ation is noted to be the ExAC databasep22 which inc旭udes data from 
the aggregation and ana旭ysis of high､ qua旭ity exome sequence data 
for 葦グ ゼグ葦 individua旭s of diverse ancestries generated as part of the 
Exome Aggregation Consortium ｪExACｫs It is p旭ausib旭ep thereforep that 
a旭though the variants have previous旭y been notedp they are causative 
of a mi旭d reduction in p旭ate旭et count that hasp or has notp been previ-
ous旭y diagnosed in a旭旭 other patients with the shared variants To de-
termine the rea旭ity of this wou旭d require further conformationa旭 works
Comparing pathogenicity prediction and variant c旭assification to 
the variants determined by WES ana旭ysisp a 旭arger percentage of vari-
ants were deemed to be of unknown significances This may ref旭ect a 
reduced rate of sensitivity and a higher proportion of fa旭se negative 
variants identifieds Howeverp it is worth considering that the ma-
jority of variantsp 葦ゴ鯵 ｪゴザ of ザゼｫp disp旭ayed supporting evidence of 
pathogenicity but 旭acked sufficient evidence to be c旭assified as suchs 
This cou旭d potentia旭旭y be an indication of the 旭ack of strengthening 
evidence that is norma旭旭y provided in the form of re旭ated affected 
fami旭y members that wou旭d be recruited to the studyp negative旭y af-
fecting c旭assification because of a 旭ack of segregation ana旭ysiss
The presence of a variant in MYH9 in patient 葦ジ high旭ights 
the difficu旭ty of picking up such defects despite the routine 
pre､ screening for disorders such as BSS､ and MYHゾ､ re旭ated 
disease ｪusing f旭ow cytometry or the presence of granu旭ocyte 
inc旭usionsp respective旭yｫ in hemophi旭ia care centers before re-
cruitment to the UK､ GAPP studys This was a旭so the case in our 
previous study where we emp旭oyed WES and detected MYHゾ 
and BSS defects despite pre､ screening by the referring 旭abora-
toriess12 Ana旭yzing patients using the IT､ specific pane旭 has e旭uci-
dated variants in genes known to cause BSS､ and MYHゾ､ re旭ated 
disease in seven patientss With the exception of patients ズグ 
and 葦ズp who present with the characteristic increase in MPV 
to the magnitude of observab旭e giant p旭ate旭etsp the remaining 
patients show an una旭tered MPVs No D塾h旭e､ 旭ike body 旭eukocyte 
inc旭usions were noted on periphera旭 b旭ood smears of patients 
葦ジ and 葦ズ and no patients presented with secondary symptoms 
re旭ating to specific IT disorderss However it shou旭d be noted 
that not a旭旭 MYHゾ defects are associated with the presence 
of Doh旭e､ 旭ike bodies in a periphera旭 b旭ood smears The defects 
identified may therefore be causative of non､ typica旭 forms of 
BSS､ and MYHゾ､ re旭ated IT but in order to exc旭ude a MYHゾ de-
fect conc旭usive旭yp immunof旭uorescence shou旭d be performed 
for the non､ musc旭e myosin heavy chain proteins
A phenotype､ genotype corre旭ation is often uti旭ized in aiding 
in the diagnosis of a patients diseases Patient 葦ゲ presented with 
a marked reduction in the ce旭旭 surface 旭eve旭s of CDジゲp the inte-
grin a旭pha IIbp to around ズグ鯵 of the 旭eve旭s observed compared 
to the trave旭 contro旭 tested simu旭taneous旭ys When ana旭yzed by 
the IT､ specific NGS pane旭 a missense variant was identified in 
ITGA2Bs This variantp csゴジゲゼG┒Ap psSer芦グ葦Asnp is nove旭 within 
a旭旭 databases but predicted benign and not we旭旭 conserved at 
the site of variations The variant occurs within the extrace旭旭u-
旭ar domain and the integrin a旭pha IIb heavy chains A旭though not 
predicted top the reduction in ce旭旭 surface CDジゲ is indicative of 
the possibi旭ity that the variant in ITGA2B affects either protein 
旭eve旭s or ce旭旭u旭ar 旭oca旭ization potentia旭旭y 旭eading to the observed 
p旭ate旭et､ based b旭eeding phenotypes This is the on旭y occurrence 
of a genotype､ phenotype corre旭ation in a旭旭 patients ana旭yzed by 
the IT､ specific NGS pane旭s A旭though three variants were identi-
fied in ITGA2B and one variant was identified in GP1BA p none of 
the patientsp with the exception of 葦ゲp were observed to have 
a reduction in the corresponding ce旭旭 surface receptor 旭eve旭ss
Interesting旭y a reduction in ce旭旭 surface expression of CDジゴbp 
encoded by GP1BAp was noted in patient ズグp who harbors a poten-
tia旭旭y de旭eterious 旭arge de旭etion of GP1BB that spans two previous旭y 
reported disease､ causing variantssゴザpゴジ A旭though not occurring in 
the encoded genep the variantp due to the detrimenta旭 effect of a 
frameshift causing de旭etionp may have propensity to disrupt the sta-
bi旭ity of the receptor comp旭ex 旭eading to a reduction in ce旭旭 surface 
expressions
As with variants determined by WES ana旭ysisp the variants ob-
served fo旭旭owing the app旭ication of the IT､ specific NGS pane旭 require 
further conformationa旭 work to be determined disease causings 
Further work wou旭d focus around this point main旭yp uti旭izing many of 
the biomarkers of disease attributed to variants in certain genes and 
recruiting re旭ated affected fami旭y members of previous旭y ana旭yzed 
patientss This wi旭旭 strengthen any initia旭 genetic variants that may be 
indicative of disease through segregation ana旭ysis but it a旭so has the 
propensity to spread disease awareness of an under recognized and 
under､ diagnosed genetic disorders
A possib旭e 旭ack of genotype･phenotype corre旭ation shown in 
patients harboring variants in ITGA2Bp GP1BAp and MYH9 in par-
ticu旭ar is an interesting observationp howeverp further work wou旭d 
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be needed to va旭idate thiss The possibi旭ity that these variants are 
disease causing rests on the functiona旭 confirmation of the effect 
of variations Howeverp if causativep the patients represent a unique 
subset of each individua旭 disease that does not share the typica旭 
phenotypic presentation of previous casess The 旭ike旭ihood that pa-
tients exist without the secondary symptoms and qua旭itative de-
fects in p旭ate旭et function attributed to these disorders is therefore 
re旭ative旭y highs
Seven patients in tota旭 were observed without any variants in 
genes of the IT､ specific pane旭s The sequencing pane旭 emp旭oyed did 
not 旭ook at Copy Number Variations ｪCNVsｫ which cou旭d be present in 
the remaining patients studieds Due to the absence of variants within 
the pane旭 of ザグ genesp there is a high chance that the genetic etio旭ogy 
of disease is due to variants in nove旭 genes not previous旭y imp旭icated 
in ITs Ana旭ysis of these patients in particu旭ar may progress our cur-
rent know旭edge of IT through the determination of nove旭 causative 
geness25
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